Subject Index
Total Page:16
File Type:pdf, Size:1020Kb
Subject Index [ [ A2M, see 2-macroglobulin ALA, see -linolenic acid anorgasmia 102, 105, 503 AAS, see anabolic-androgenic steroid albumin 419 antegrade ejaculation 37 AAV, see adeno-associated virus alcoholism 58, 349 anti-ageing 565 aberrant mammary tissue (AMT) 235 alfuzosin 540 –products624 ABP, see androgen-binding protein allergic contact dermatitis 198 antiandrogen 21 [ accessory gland infection 78 allodynia 172 1-antichymotrypsin (ACT) 417 Achenbach questionnaire 610 Alzheimer’s disease 252 anti-doping rules 556 acne 622 amantadine 54 anti-Müllerian hormone (AMH) 266, acquired immunodeficiency syndrome amenorrhoea 469 269, 305, 410, 458 (AIDS) 131, 331, 586 AMH, see anti-Müllerian hormone anti-oestrogen 518 – testicular atrophy 333 amitriptyline 174 antioxidant 46, 573, 625 acquired testicular damage 66 ammonia dermatitis 207 antisperm antibody (ASA) 31, 44, 47, acromegaly 76 amniocentesis 65 154, 298 acrosin 389, 392 amoxicillin 73 Apert syndrome 473 acrosomal hypoplasia 399 AMP, see adenosine monophosphate apomorphine 285, 530 acrosome reaction 50, 276, 301 AMT, see aberrant mammary tissue apoptosis 294 [ ACT, see 1-antichymotrypsin anabolic steroid 75, 87 appendix testis 140 ACTH, see adrenocorticotropin anabolic-androgenic steroid (AAS) AR, see androgen receptor acute 555 ARCT, see ATP release cytotoxicity – appendicitis 145 – abuse 557 test – bacterial prostatitis 218 anaerobe 403 areolar sebaceous hyperplasia 233 –epididymitis145 analbuminaemia 419 arginine 575 – scrotum 138, 139, 145 analogue assay 409 aromatase 410 ––surgery 146 anastomosis 341, 503, 507 – inhibitor 240, 518 – urinary infection 217 androgen 21, 28, 77, 226, 516, 555 ART, see assisted reproduction technol- ADAM – deficiency 359, 376 ogy – family 301 –derivatives517 arterial flow 339 – score 552 – insensitivity syndrome (AIS) 23, artificial insemination with husband’s Addison’s disease 563 270, 310 semen (AIH) 11 adeno-associated virus (AAV) 66, 126 – – partial form (PAIS) 270 ASA, see antisperm antibody adenosine – receptor (AR) 242, 270, 367 ascorbic acid 625 – diphosphate (ADP) 392 –sideeffects22 aspermatogenesis 296 – monophosphate (AMP) 392 androgen-binding protein (ABP) 261, aspermia 54, 359 – triphosphate (ATP) 48, 392 278 assisted reproduction technology ––release cytotoxicity test (ARCT) 48 andrology (ART) 586, 572, 610 adjuvant hormonal ablation therapy – consent form for treatment 10 astaxanthin 574 545 – cost-effectiveness 7 asthenozoospermia 31, 77 ADP, see adenosine diphosphate – definition 1 atherosclerosis 340, 526 ADPKD, see autosomal dominant poly- – evidence-based medicine 5 atopic dermatitis 199 cystic kidney disease – international development 2 atrophy 151, 152 [ -adrenergic blocking agent 215 – tumour markers 415 ATRX, see alpha-thalassaemia-mental- adrenocorticotropin (ACTH) 310, 562 androstenedione 243 retardation-X-linked aesthetic andrology 621, 632 anejaculation 35, 359 autoimmune orchitis 122, 295 AFP, see alpha fetoprotein – obstructive 100 autosomal dominant polycystic kidney ageing 250, 561 aneuploidy in sperm cell 354 disease (ADPKD) 437 –oftheskin623 Angell’s sign 142 average life expectancy 565 agenesis of the epididymal tail 432 Angelman syndrome 302 AZF, see azoospermia factor agglutination test 48 angina 217 azoospermia 58, 64, 115, 116, 187, AHA, see alpha-hydroxy acid angiodynography 144 343, 351, 433, 454, 522 AIDS, see acquired immunodeficiency angiogenesis 420 – factor (AZF) 582 syndrome angioleiomyoma 234 – non-obstructive 81, 465 AIH, see artificial insemination with angioma senile 233 – obstructive 81, 432, 470 husband’s semen anorchia 413 636 Subject Index bacterial infection 73, 323 carnitine 569 complex regional pain syndrome 172 balanitis 191, 206, 404 – L-carnitine 574 compulsive sexual behaviour (CSB) –circinata194 CASA, see computer-assisted semen 109 – circumscripta plasmacellularis 193, analysis computer-assisted semen analysis 194 catheterization 510 (CASA) 389 – xerotica obliterans (BXO) 206 cavernosal concealed penis 620 balanoposthitis 191, 192, 206, 210 –artery 339 congenital basal cell carcinoma (BCC) 234 – blood gas value 167 – adrenal hyperplasia (CAH) 23 BCC, see basalcellcarcinoma cavernosography 88, 165 ––salt-wastingform 24 Beckwith Wiedemann syndrome 473 CBAVD, see congenital bilateral ab- – anorchia 410 bell-clapper deformity 135, 136, 150 sence of the vas deferens – bilateral absence of the vas deferens benign prostate hyperplasia (BPH) CC, see clomiphene citrate (CBAVD) 83, 433, 470 213, 252, 416 centrifugation 117 contact thermography 448, 451 – brachytherapy 215 cephalosporin 73 continuous wave Doppler (CW) 437 – radical prostatectomy 215 cervical mucus 300 contraception – radiotherapy 215 cervicitis 330 – condoms 123 – therapy 535 cervonic acid 572 – periodic abstinence 123 – watchful waiting 539 CFU, see colony forming unit – traditional methods 122 bicalutamide 226, 547 CGA, see chromogranin A – withdrawal 123 biggerexia 557 Char syndrome 235 controlled ovarian hyperstimulation bioflavonoid 222 chemical (COH) 580 bladder neck function 101 –browlift628 cord bladder outlet obstruction (BOO) – peeling 630 – denervation 175 538, 540 chlamydia (C.) 73, 221, 325, 329, 378 –hydrocele181 bladder overactivity 376 –infection129 – torsion 344 bleomycin 186 – pneumoniae 330 cordyceps sinensis 569 blockade of nerve 174 – trachomatis 45, 328, 330, 403, 406 corpora 491 [ -blocker 222, 254, 540 cholestasis 559 – cavernosa 264, 265 blood-epididymis barrier 297 chondroitin sulphate 569 corpus spongiosum 264, 265 blood-testis barrier (BTB) 276, 294 chordee 208 corticosteroid 548 blunt testicular trauma 162, 163 –tissue94 –therapy50 body mass index (BMI) 34, 60, 226 chromatid 274 cortisol 562 bone chromatin 330, 398 corynebacterium spp. 403 – alkaline phosphatase 418 –stability45 cosmeceutical 624 – density 552 chromogranin A (CGA) 418 cost-effectiveness 7 BOO, see bladder outlet obstruction chromosomal abnormality 63, 463 counting chamber 388 borrelia burgdorferi infection 233 chronic pain syndrome 171, 177, 495 Cowper’s gland 264, 382 botulinum toxin A 626, 630 chronicpelvicpainsyndrome 218 COX2, see cyclooxygenase-2 –application627 [ -chymotrypsin 46 craniopharyngioma 76 brain death 13 Cialis 88 crataegus 569 BRCA gene 238 circumcision 203 crater defect syndrome 399 breast cancer 527 –inadults489 creatine phosphokinase (CK) 392 – in men 228 –neonatal204 cremasteric breeding bull syndrome 599 – psychological consequences 209 –artery 260 bromelain 46 –ritual207 – reflex 141, 142 BTB, see blood-testis barrier –sexual209 – spasm 136 Buck’s fascia 164 – wound infection 207 Crohn’s disease 217 bupivacaine 485 cirrhosis 238 crow’s feet 629 buserelin 546 CIS, see carcinoma in situ cryobanking 586 BXO, see balanitis xerotica obliterans cisplatin 186 cryobiology 586 CK, see creatine phosphokinase cryoinjury 587 cachexia 556 C-KIT 369 cryopreservation 406, 585 cadmium 352 clomiphene 579 cryostorage 588 caffeine 349, 587 – citrate (CC) 558, 583 cryptorchidism 55, 78, 150, 154, 187, CAIS, see complete androgen insensi- clonal selection 364 267, 297, 311, 343, 427, 428, 458, 472 tivity syndrome clostridium botulinum 626 cryptozoospermia 31 cAMP, see cyclic adenosine monophos- CMV, see cytomegalovirus –idiopathic77 phate c-myc gene 367 CSB, see compulsive sexual behaviour cancer counselling 603 coaxial catheter 510 Cushing’s disease 412 candida albicans 126 COH, see controlled ovarian hyper- CVD, see cardiovascular disease capacitation 300 stimulation CW, see continuous wave Doppler capillary force 452 coitus interruptus 123, 383 cycle of spermatogenesis 279 carbon disulfide 353 colchicine 54 cyclic adenosine monophosphate carcinoma collagen 631 (cAMP) 587 – erysipelatoid 235 Collins knife 221 cyclooxygenase-2 (COX2) 567 – in situ (CIS) 368 colony forming unit (CFU) 388 cyclophosphamide 548 – – of the testis 187 complete androgen insensitivity syn- cyproterone acetate 21, 533, 547 cardiovascular disease (CVD) 251 drome (CAIS) 310 cystic fibrosis 59, 64, 470, 471, 475 Subject Index 637 – transmembrane conductance regula- – agonist 315 end diastolic velocity (EDV) 439 tor (CFTR) 33, 83, 465, 470, 603 doping 556 endocrine disorder 408 cytochrome P450C17 309 – control 559 endorphin 176 cytokine 153, 294, 323 Doppler technique 437 endothelin 340 cytomegalovirus (CMV) 404 dosage-sensitive sex reversal (DSS) endotoxaemia 221 cytosine methylation 473 269, 308 enterobacteriaceae spp. 403 cytoskeleton 473 Down’s syndrome 463, 475 enterococcus (E.) spp. 403 doxazosin 541 entrapment neuropathy 171 daidzein 566 doxycycline 73 enzyme-linked immunosorbent assay dartos pouch fixation 148 DRE, see digitalrectalexamination (ELISA) 49, 409 DAX-1, see DSS-ACH critical region on drosophila EPA, see eicosapentaenoic acid the X chromosome –arizonae472 epididymal DAZ gene 467 – mojavensis 472 – cyst 429, 487 DBCP, see dibromochloropropane dry skin 623 ––excision 488 DDT, see dichlorodiphenyltrichloroe- DSS, see dosage-sensitive sex reversal ––ultrasound 445 thane DSS-ACH critical region on the X chro- – tumour 445 decapitated spermatozoa 399 mosome (DAX-1) 269 epididymectomy 174, 175, 488 deferent duct 433 ductal carcinoma 238 epididymis 45, 66, 72, 74, 120, 260, degloving incision 165 ductus deferens 262 297, 373, 406 dehydroepiandrosterone (DHEA) Dupuytren’s contracture 93, 94 – adenomatoid tumour 181 243, 562, 563 Düsseldorf classification 396 – cyst 181 Denys-Drash syndrome 268, 307 dysplasia 269 –neoplasm181 deoxyribonucleic acid (DNA) 302, dysuria 72, 142, 329 – obstruction 432 462 –tuberculosis182 –methylation473